Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.

Hedges KNC, Borisov AS, Saukkonen JJ, Scott NA, Hecker EJ, Bozeman L, Dukes Hamilton C, Kerrigan A, Bessler P, Moreno-Martinez A, Arevalo B, Goldberg SV.

Clin Trials. 2019 Nov 6:1740774519885380. doi: 10.1177/1740774519885380. [Epub ahead of print]

PMID:
31690107
2.

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials.

Moro RN, Scott NA, Vernon A, Tepper NK, Goldberg SV, Schwartzman K, Leung CC, Schluger NW, Belknap RW, Chaisson RE, Narita M, Machado ES, Lopez M, Sanchez J, Villarino ME, Sterling TR.

Ann Am Thorac Soc. 2018 May;15(5):570-580. doi: 10.1513/AnnalsATS.201704-326OC.

3.

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.

Jayakumar A, Savic RM, Everett CK, Benator D, Alland D, Heilig CM, Weiner M, Friedrich SO, Martinson NA, Kerrigan A, Zamudio C, Goldberg SV, Whitworth WC, Davis JL, Nahid P.

J Clin Microbiol. 2016 Dec;54(12):3028-3033. Epub 2016 Oct 12.

4.

Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.

Moro RN, Borisov AS, Saukkonen J, Khan A, Sterling TR, Villarino ME, Scott NA, Shang N, Kerrigan A, Goldberg SV.

Clin Infect Dis. 2016 Jun 1;62(11):1390-1400. doi: 10.1093/cid/ciw126. Epub 2016 Mar 6.

5.

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; International Maternal Pediatric and Adolescents AIDS Clinical Trials Group; Tuberculosis Trials Consortium.

JAMA Pediatr. 2015 Mar;169(3):247-55. doi: 10.1001/jamapediatrics.2014.3158. Erratum in: JAMA Pediatr. 2015 Sep;169(9):878.

6.

Evaluation of the Informed Consent Process of a Multicenter Tuberculosis Treatment Trial.

Chapman KN, Pevzner E, Mangan JM, Breese P, Lamunu D, Shrestha-Kuwahara R, Nakibali JG, Goldberg SV.

AJOB Empir Bioeth. 2015;6(4):31-43. doi: 10.1080/23294515.2015.1015184. Epub 2015 Feb 19.

7.

Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.

Reves R, Heilig CM, Tapy JM, Bozeman L, Kyle RP, Hamilton CD, Bock N, Narita M, Wing D, Hershfield E, Goldberg SV; Tuberculosis Trials Consortium.

Int J Tuberc Lung Dis. 2014 May;18(5):571-80. doi: 10.5588/ijtld.13.0304.

PMID:
24903795
8.

What is the most reliable solid culture medium for tuberculosis treatment trials?

Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD.

Tuberculosis (Edinb). 2014 May;94(3):311-6. doi: 10.1016/j.tube.2014.03.002. Epub 2014 Mar 19.

PMID:
24698569
9.

How we determined the most reliable solid medium for studying treatment of tuberculosis.

Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV.

Tuberculosis (Edinb). 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006. Epub 2014 Mar 4.

10.

The association between symptoms and microbiologically defined response to tuberculosis treatment.

Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ.

Ann Am Thorac Soc. 2013 Feb;10(1):18-25. doi: 10.1513/AnnalsATS.201207-038OC.

11.

Outbreak of tuberculosis in a homeless population involving multiple sites of transmission.

Lofy KH, McElroy PD, Lake L, Cowan LS, Diem LA, Goldberg SV, Cangelosi GA, Tribble SP, Cave MD, Narita M.

Int J Tuberc Lung Dis. 2006 Jun;10(6):683-9.

PMID:
16776457
12.

Pooling tides: the convergence of migration, congregation, and tuberculosis.

Goldberg SV.

Int J Tuberc Lung Dis. 2005 May;9(5):475. No abstract available.

PMID:
15875915
13.

Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains.

Cangelosi GA, Freeman RJ, Lewis KN, Livingston-Rosanoff D, Shah KS, Milan SJ, Goldberg SV.

J Clin Microbiol. 2004 Jun;42(6):2685-93.

14.

Expanded geographical distribution of the N family of Mycobacterium tuberculosis strains within the United States.

Milan SJ, Hauge KA, Kurepina NE, Lofy KH, Goldberg SV, Narita M, Nolan CM, McElroy PD, Kreiswirth BN, Cangelosi GA.

J Clin Microbiol. 2004 Mar;42(3):1064-8.

15.

Cultural case management of latent tuberculosis infection.

Goldberg SV, Wallace J, Jackson JC, Chaulk CP, Nolan CM.

Int J Tuberc Lung Dis. 2004 Jan;8(1):76-82.

PMID:
14974749
16.
17.

Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.

Goldberg SV, Hanson D, Peloquin CA.

Clin Infect Dis. 2003 Aug 15;37(4):607-8. No abstract available.

PMID:
12905149
18.
19.

Four-month, four-drug preventive therapy for inactive pulmonary tuberculosis.

Goldberg SV, Duchin JS, Shields T, Nolan CM.

Am J Respir Crit Care Med. 1999 Aug;160(2):508-12.

PMID:
10430721
20.
21.

Tuberculosis prevention among foreign-born persons in Seattle--King County, Washington.

Wells CD, Zuber PL, Nolan CM, Binkin NJ, Goldberg SV.

Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):573-7.

PMID:
9279242
22.

Directly observed isoniazid preventive therapy for released jail inmates.

Nolan CM, Roll L, Goldberg SV, Elarth AM.

Am J Respir Crit Care Med. 1997 Feb;155(2):583-6.

PMID:
9032198
23.

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.

Nolan CM, Williams DL, Cave MD, Eisenach KD, el-Hajj H, Hooton TM, Thompson RL, Goldberg SV.

Am J Respir Crit Care Med. 1995 Sep;152(3):1067-71.

PMID:
7663785
24.

Diuretic effect of acute hypoxia in humans: relationship to hypoxic ventilatory responsiveness and renal hormones.

Swenson ER, Duncan TB, Goldberg SV, Ramirez G, Ahmad S, Schoene RB.

J Appl Physiol (1985). 1995 Feb;78(2):377-83.

PMID:
7759405
25.

Brain tissue pH and ventilatory acclimatization to high altitude.

Goldberg SV, Schoene RB, Haynor D, Trimble B, Swenson ER, Morrison JB, Banister EJ.

J Appl Physiol (1985). 1992 Jan;72(1):58-63.

PMID:
1537744
26.

Exercise breathing pattern during chronic altitude exposure.

Mekjavic IB, Moric C, Goldberg SV, Morrison JB, Walsh ML, Banister EW, Schoene RB.

Eur J Appl Physiol Occup Physiol. 1991;62(1):61-5.

PMID:
2007398

Supplemental Content

Loading ...
Support Center